Nature's Fynd Stock
Nutritional Vegan Protein
Sign up today and learn more about Nature's Fynd Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Nature's Fynd Stock
Nature’s Fynd describes itself as a food company growing a protein called Fy™ from a microbe with origins in the geothermal springs of Yellowstone National Park. Nature's Fynd claims that Fy is a nutritional fungi protein that uses only a fraction of the resources required by traditional agriculture.
Nature’s Fynd was founded in 2012 and is headquartered in Chicago, Illinois. Notable investors include 1955 Capital, SoftBank Vision Fund, and Breakthrough Energy Ventures.
Investors
Balyasny Asset Management
Farmers Business Network, Nature's Fynd, Orbital Insight, Zola
Blackstone Group
goPuff, Weee!, Epidemic Sound, Nature's Fynd, Carbon Health, Clari, Vectra, Wiz, VTS, Oatly
Breakthrough Energy Ventures
Nature's Fynd, QuantumScape, Pivot Bio, Turntide Technologies, Commonwealth Fusion, CarbonCure Technologies
Danone Manifesto Venture
EDBI
Magic Leap, DataRobot, Nature's Fynd, Voyager Innovations, Welltok, Seismic, Inari, WuXi NextCODE, Sprinklr, Druva
Generation Investment Management
DocuSign, Convoy, Nature's Fynd, Proterra, Pivot Bio, Remitly, Optoro, Guideline, Andela, Asana
Hillhouse Capital Group
Market Kurly, Swiggy, Grail, Traveloka, Coalition, Nature's Fynd, Airwallex, Omio
Lauder Partners
Mousse Partners
Oxford Finance Corporation
SK Holdings
Trinity Capital
Funding History
| May 2018 | $33.1M |
|---|---|
| February 2020 | $80.2M |
| June 2021 | $634M |
Management
Chief Executive Officer
Thomas Jonas
Chief Financial Officer
Matthew Strongin
Chief Technology Officer
Jim Mills
Press
bizjournals - Oct, 28 2021
Nature's Fynd to open massive South Side facility as its meatless products hit shelvesagfundernews - Mar, 24 2020
Nature’s Fynd rebrands from Sustainable Bioproducts raising $80m Series B to launch new protein food productsfinsmes - Feb, 4 2019
Sustainable Bioproducts Raises $33M in Series A Financingchicagobusiness - Feb, 4 2019
Bezos-backed fund invests in Chicago protein startupEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
